PORTAGE, Mich.--(BUSINESS WIRE)--Stryker (NYSE:SYK), a global leader in medical technologies, announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Incompass® ...
The U.S. Food and Drug Administration (FDA) is warning patients and healthcare providers of a “higher than expected risk” of failure in Stryker Scandinavian Total Ankle Replacement (STAR) devices.
The U.S. Food and Drug Administration on Monday issued a safety advisory on Stryker’s Scandinavian Total Ankle Replacement, or STAR Ankle, devices, citing the risk of a plastic component breaking ...
Patients younger than 55 years old or who have a more active lifestyle, as well as those with osteoarthritis, may have a higher risk of the plastic breaking, the FDA said. (Getty Images) () The FDA is ...
Stryker SYK recently received FDA clearance for its InCompass Total Ankle System, marking a pivotal expansion in the company's Foot & Ankle portfolio. Designed to address end-stage ankle arthritis, ...
PORTAGE, Mich.--(BUSINESS WIRE)-- Stryker (NYSE:SYK), a global leader in medical technologies, will launch its Incompass™ Total Ankle System at the 2025 American Orthopaedic Foot & Ankle Society ...
MAHWAH, N.J.--(BUSINESS WIRE)--Stryker today launched the Prophecy ® Infinity ® Resect-Through Guides for use in total ankle replacement surgeries. The system represents the latest refinement of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results